Skip to content

Sections
- Health
- Pharma
- Biotech
- Hospitals
- Politics
- In the Lab
- First Opinion
- Gut Check
- The Watchdogs
Topics
- Cancer
- Concussions
- CRISPR
- Drug Pricing
- End of Life
- Health Disparities
- Immigration
- Opioids
- Trump
- Women’s Health
- Zika
Multimedia
Popular
STAT Plus

Job Board
About

Newsletters
My Account
- Settings
- Log Out

Newsletters
My Account
- Settings
- Log Out

Most Popular

Check out the most popular stories and multimedia features across the site right now

State of (Trump's) Mind

Trump wasn’t always so linguistically challenged. What could explain the change?

By Sharon Begley

Special Report

The addict brokers: Middlemen profit as desperate patients are ‘treated like paychecks’

By David Armstrong — STAT and Evan Allen — Boston Globe

advertisement

Health

Researcher with stage 4 cancer launches site to help others navigate clinical trials

By Bob Tedeschi

advertisement

Health

Reporter’s notebook: I never thought I’d be writing about Trump’s mind

By Sharon Begley

In the Lab

This smells promising: Nasal bacteria pump out a new antibiotic that kills MRSA

By Anna Vlasits

In the Lab

They’re going to CRISPR people. What could possibly go wrong?

By Sharon Begley

Biotech

While no one says ‘cure,’ the pipeline for ALS treatments looks more promising

By Andrew Joseph

advertisement

Health

Ebola outbreak may be smaller than feared, WHO indicates

By Helen Branswell

advertisement

Video

Can fidget spinners actually relieve symptoms of ADHD and autism?

By Megan Thielking and Alex Hogan

First Opinion

Lessons learned from the final Ebola outbreak in Guinea

By Ngozi Erondu

Health

You may have more control over aging than you think, say ‘The Telomere Effect’ authors

By Karen Weintraub

Politics

Looming question for medical students: Will they be shut out of advanced training?

By Melissa Bailey

Business

Autofocus contact lens being developed by Verily and Alcon suffers delay

By Charles Piller

Hospitals

‘We were lucky’: 5 takeaways for US hospitals in wake of ransomware attack

Business

New Parkinson’s drug could reduce hallucinations, but at what cost?

By Bob Tedeschi

Don't Miss

To keep seniors living independently, sensors track their home habits

By Eric Boodman

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.

Reporting from the frontiers of health and medicine

About
Contact Us
The STAT Team
Work at STAT
Job Board
Advertise

Privacy
Comment Policy
Terms

© 2017 STAT